Regina Barber

OK, but Rachel, this week we also have been talking about whether the trip could actually be like helping patients, like the whole journey that comes with taking a drug like psilocybin.

And by that, he means the effect they have on our brains.

And by that, he means the effect they have on our brains.

And by that, he means the effect they have on our brains.

Rachel, thank you so much for joining me this week to talk about all of this. Like, you've really made me think. I've learned a lot. Anytime, Gina. Thank you so much for having me. And for listeners who didn't hear the first two episodes, we definitely recommend checking them out. There's a lot of nuance. They're just the previous two episodes in the shortwave feed.

Rachel, thank you so much for joining me this week to talk about all of this. Like, you've really made me think. I've learned a lot. Anytime, Gina. Thank you so much for having me. And for listeners who didn't hear the first two episodes, we definitely recommend checking them out. There's a lot of nuance. They're just the previous two episodes in the shortwave feed.

Rachel, thank you so much for joining me this week to talk about all of this. Like, you've really made me think. I've learned a lot. Anytime, Gina. Thank you so much for having me. And for listeners who didn't hear the first two episodes, we definitely recommend checking them out. There's a lot of nuance. They're just the previous two episodes in the shortwave feed.

This episode was produced by Hannah Chin, and it was edited by Rebecca Ramirez and Jeff Brumfield. Tyler Jones checked the facts. Maggie Luthar was the audio engineer. Beth Donovan is our senior director, and Colin Campbell is our senior vice president of podcasting strategy. I'm Regina Barber. Thank you for listening to Shortwave from NPR.

This episode was produced by Hannah Chin, and it was edited by Rebecca Ramirez and Jeff Brumfield. Tyler Jones checked the facts. Maggie Luthar was the audio engineer. Beth Donovan is our senior director, and Colin Campbell is our senior vice president of podcasting strategy. I'm Regina Barber. Thank you for listening to Shortwave from NPR.

This episode was produced by Hannah Chin, and it was edited by Rebecca Ramirez and Jeff Brumfield. Tyler Jones checked the facts. Maggie Luthar was the audio engineer. Beth Donovan is our senior director, and Colin Campbell is our senior vice president of podcasting strategy. I'm Regina Barber. Thank you for listening to Shortwave from NPR.

You're listening to Shortwave from NPR. Hey, Short Wavers, Regina Barber here. I'm talking with one of our producers, Rachel Carlson, who's been reporting a series on psychedelics and related drugs. Hey, Rachel. Hi, Gina.

You're listening to Shortwave from NPR. Hey, Short Wavers, Regina Barber here. I'm talking with one of our producers, Rachel Carlson, who's been reporting a series on psychedelics and related drugs. Hey, Rachel. Hi, Gina.

You're listening to Shortwave from NPR. Hey, Short Wavers, Regina Barber here. I'm talking with one of our producers, Rachel Carlson, who's been reporting a series on psychedelics and related drugs. Hey, Rachel. Hi, Gina.

Definitely check out that episode if you missed it, but also this one will make sense without it. Rachel, you touched on one thing in that episode that we're going to go a little deeper on today, and that's the challenge of studying these drugs.

Definitely check out that episode if you missed it, but also this one will make sense without it. Rachel, you touched on one thing in that episode that we're going to go a little deeper on today, and that's the challenge of studying these drugs.

Definitely check out that episode if you missed it, but also this one will make sense without it. Rachel, you touched on one thing in that episode that we're going to go a little deeper on today, and that's the challenge of studying these drugs.

So today on the show, the creative ways some researchers are trying to navigate research on drugs like psychedelics and ketamine.

So today on the show, the creative ways some researchers are trying to navigate research on drugs like psychedelics and ketamine.

So today on the show, the creative ways some researchers are trying to navigate research on drugs like psychedelics and ketamine.

I'm Rachel Carlson. And I'm Regina Barber. You're listening to Shortwave, the science podcast from NPR. OK, Rachel, so when people say drugs like psychedelics and ketamine can help treat different conditions, there could be a few things happening.